Clinical Case: Choosing an OTC Antihistamine for Seasonal Allergy
A patient requests allergy relief for the first time. An educational case on antihistamine selection, drowsiness, and counseling for daily activities.
PharmaSim · Updated
Educational material; no clinical peer review is claimed. Methodology and limitations
Fictional teaching case, not a real patient record or a simulator answer key.
Patient presentation
A 28-year-old woman asks for something for her hay fever, which has just started this season. She has itchy eyes, a runny nose, and sneezing. She drives to work and works in an office.
History
No chronic conditions. No regular medications. She has not tried antihistamines before. She is not pregnant. She drives daily and needs to be alert at work.
Medication information
Over-the-counter antihistamine (to be selected).
Clinical problem
The patient needs effective allergy relief that does not impair her driving or work. First-generation antihistamines (chlorphenamine, diphenhydramine) cause sedation and are unsuitable for someone who drives and needs alertness. Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are minimally sedating and the appropriate choice.
Important considerations
- First-generation antihistamines cause sedation and impair driving and concentration.
- Second-generation antihistamines are minimally sedating and are the default for most adults.
- A small percentage of people still feel drowsy on second-generation antihistamines; counsel to test the first dose on a day off.
- Severe or persistent symptoms, or symptoms not typical of allergy, may warrant referral.
Questions for the learner
- Which antihistamine generation is appropriate for this patient, and why?
- What counseling do you give about drowsiness and the first dose?
- What non-drug advice complements the antihistamine?
- When would you refer this patient rather than recommend an OTC product?
Clinical reasoning
The pharmacist selects a second-generation antihistamine (for example, cetirizine or loratadine) because the patient drives and needs alertness. They explain that the product is non-drowsy for most people, but that a small number still feel sleepy, so the first dose should be taken on a day off to test tolerance. They counsel on once-daily dosing, on avoiding first-generation alternatives that would cause drowsiness, and on non-drug measures such as pollen avoidance. They screen for red flags (such as wheeze or facial pain suggesting something beyond simple allergy) and find none. The patient leaves with an appropriate product and clear advice.
Possible approaches
- Select a sedating antihistamine without asking about driving.
- Assess typical allergy symptoms, respiratory red flags and practical risks before selecting relief.
- Promise a second-generation drug can never cause drowsiness. This gives unsafe reassurance.
Safer approach
For the described uncomplicated nasal and eye symptoms, consider a less-sedating eligible treatment after checking contraindications. Cetirizine, loratadine and fexofenadine do not have identical drowsiness or dosing profiles. Significant nasal symptoms may benefit from an appropriate intranasal option. Explain the selected product rather than promising the entire class is safe for driving.
Counseling points
- Do not drive if sleepy or impaired; check alcohol, other sedatives and kidney-related restrictions.
- Discuss allergen measures and how to use a chosen nasal product correctly; reassess persistent symptoms rather than doubling doses.
Red flags and urgency
- Airway swelling, breathing difficulty or faintness may be anaphylaxis; wheeze, fever, severe facial pain or atypical unilateral symptoms needs assessment.
Key learning points
- Second-generation antihistamines are the default for adults who need to stay alert.
- Counsel that a small percentage still feel drowsy; test the first dose on a day off.
- Non-drug measures (pollen avoidance, nasal irrigation) complement antihistamines.
- Red flags (wheeze, facial pain, persistent symptoms) warrant referral.
Sources and references
- NHS: Antihistamines
- FDA: Drug Interactions, What You Should Know
- NICE NG5: Medicines optimisation
- AHRQ: Use the Teach-Back Method, Tool 5
Sources reflect their own jurisdictions. For real practice, check the current product label and local guidance.
Practice this case in the simulator
Step into the interactive scenario and make the decisions yourself.
Start SimulationRelated Knowledge Base articles
PharmaSim is an educational simulation designed for learning and practice. It does not replace formal pharmacy education, clinical training, official prescribing information, professional supervision, or professional judgment.